A mental disorder is also called as mental illness or a psychiatric disorder. Mental disorders are generally defined according to how an individual behave, feels, perceives and thinks, and mental disorder occurs due to damage or problems associated with functions of brain. There are various types of mental disorders such as depression, bipolar disorder, schizophrenia and other psychoses, dementia, and developmental disorders including autism.
These disorders can be treated with the help of various medications such as anti-depressants, antianxiety drugs and can also be treated with self-help therapies such as psychotherapy, brain stimulation treatments, and others.
This report contains market size and forecasts of Mental Disorder Treatment in Global, including the following market information:
Global Mental Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Mental Disorder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mental Disorder Treatment include Allergan Plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V, Amneal Pharmaceuticals LLC, Cipla Ltd and Sun Pharmaceutical Industries Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mental Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mental Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Mental Disorder Treatment Market Segment Percentages, by Type, 2021 (%)
Medications
Self-help Therapies
Global Mental Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Mental Disorder Treatment Market Segment Percentages, by Application, 2021 (%)
Depression
Bipolar Disorder
Schizophrenia
Dementia
Post-traumatic Stress Disorder
Others
Global Mental Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Mental Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mental Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Mental Disorder Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc
Eli Lilly and Company
VistaGen Therapeutics
Sanofi S.A
Novartis International AG
Mylan N.V
Amneal Pharmaceuticals LLC
Cipla Ltd
Sun Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Limited
Lupin Limited
Janssen Pharmaceutica
Bristol Myers Squibb
Sumitomo Dainippon Pharma Co., Ltd